Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of MF59-adjuvanted vs Non-adjuvanted Influenza Vaccine in CKD Patients
NCT02686398Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by Korea University Guro Hospital. Started Oct 2013; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02686398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686398.